Gonadal toxicity following cancer therapy in adults: significance, diagnosis, prevention and treatment.
Kreuser
E D
ED
Department of Internal Medicine (Hematology and Oncology), Free University of Berlin, Steglitz Medical Center, Federal Republic of Germany.
Hetzel
W D
WD
Billia
D O
DO
Thiel
E
E
D000208:Acute Disease; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D003267:Contraception; D003376:Counseling; D015914:Estrogen Replacement Therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy; D010049:Ovarian Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D010053:Ovary / Q000187:drug effects*; D013733:Testicular Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D013737:Testis / Q000187:drug effects*; D013739:Testosterone / Q000097:blood
D000970:Antineoplastic Agents; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone